أعرض في EDS

PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

التفاصيل البيبلوغرافية
العنوان: PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
المؤلفون: David Z. Chang, Vincent Chung, Navreet Dhindsa, Khalid Mamlouk, Richard A. Hubner, Andrea Wang-Gillam, Niall C. Tebbutt, D. D. Von Hoff, Fabio Franke, Prasad Cooray, Bruce Belanger, Paul Ross, L.-T. Chen, Tomislav Dragovich, Shubham Pant, Jens T. Siveke, F. de Jong
بيانات النشر: Oxford University Press, 2016.
سنة النشر: 2016
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Phases of clinical research, Hematology, Gemcitabine, 03 medical and health sciences, Abstracts, 030104 developmental biology, 0302 clinical medicine, Text mining, Pancreatic Cancer Stage IV, Fluorouracil, 030220 oncology & carcinogenesis, Internal medicine, Metastatic pancreatic cancer, medicine, Previously treated, business, medicine.drug
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66aeffc01089ae994dc557598aa69350
https://europepmc.org/articles/PMC4984171/
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....66aeffc01089ae994dc557598aa69350
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.